A Prospective Study of Serum Pancreatic Elastase-1 in the Diagnosis and Assessment of Acute Pancreatitis

1998 ◽  
Vol 33 (6) ◽  
pp. 664-668 ◽  
Author(s):  
C. E. MILLSON, K. CHARLES, P. POON,
Author(s):  
Su‐Fen Chi ◽  
Chia‐Yeh Lai ◽  
Wei‐Ting Dong ◽  
Jiunn‐Min Wang ◽  
Ya‐Yu Wang ◽  
...  

1993 ◽  
Vol 218 (1) ◽  
pp. 17-27 ◽  
Author(s):  
Hidehisa Asada ◽  
Kazunori Shibata ◽  
Kiyohisa Uchida ◽  
Yoshifumi Takeyama ◽  
Yoichi Saitoh ◽  
...  

Diabetes Care ◽  
2006 ◽  
Vol 29 (3) ◽  
pp. 719-721 ◽  
Author(s):  
F. Cavalot ◽  
K. Bonomo ◽  
E. Fiora ◽  
E. Bacillo ◽  
P. Salacone ◽  
...  

2017 ◽  
Vol 312 (6) ◽  
pp. G606-G614 ◽  
Author(s):  
Anna Zsófia Tóth ◽  
András Szabó ◽  
Eszter Hegyi ◽  
Péter Hegyi ◽  
Miklós Sahin-Tóth

Determination of fecal pancreatic elastase content by ELISA is a reliable, noninvasive clinical test for assessing exocrine pancreatic function. Despite the widespread use of commercial tests, their exact molecular targets remain poorly characterized. This study was undertaken to clarify which human pancreatic elastase isoforms are detected by the ScheBo Pancreatic Elastase 1 Stool Test and whether naturally occurring genetic variants influence the performance of this test. Using recombinantly expressed and purified human pancreatic proteinases, we found that the test specifically measured chymotrypsin-like elastases (CELA) 3A and 3B (CELA3A and CELA3B), while CELA2A was not detected. Inactive proelastases, active elastases, and autolyzed forms were detected with identical efficiency. CELA3B elicited approximately four times higher ELISA signal than CELA3A, and we identified Glu154in CELA3B as the critical determinant of detection. Common genetic variants of CELA3A and CELA3B had no effect on test performance, with the exception of the CELA3B variant W79R, which increased detection by 1.4-fold. Finally, none of the human trypsin and chymotrypsin isoforms were detected. We conclude that the ScheBo Pancreatic Elastase 1 Stool Test is specific for human CELA3A and CELA3B, with most of the ELISA signal attributable to CELA3B.NEW & NOTEWORTHY The ScheBo Pancreatic Elastase 1 Stool Test is widely used to assess pancreatic exocrine function, yet its molecular targets have been poorly defined. We demonstrate that, among the human pancreatic proteinases, the test measures the elastase isoform CELA3B and, to a lesser extent, CELA3A. Genetic variants of the human CELA3 isoforms have no significant effect on test performance.


1977 ◽  
Vol 53 (620) ◽  
pp. 310-314 ◽  
Author(s):  
D. Murphy ◽  
C. W. Imrie ◽  
J. F. Davidson

2021 ◽  
Vol 8 (11) ◽  
pp. 643-647
Author(s):  
Rama Krishna Narra ◽  
Manjeera Boddepalli ◽  
Narasimhachary Munjuwanpalli ◽  
Bhimeswarao Pasupaleti

BACKGROUND Acute pancreatitis (AP) is described as acute inflammation of the pancreas with or without peripancreatic abnormalities. The present study describes the role of computed tomography in the evaluation and grading of acute pancreatitis. Acute pancreatitis is a dynamic disease having biphasic mortality peaks due to two overlapping phases, which include early and late due to increased obesity, ageing of population, alcohol abuse, increased gall stone incidence, the worldwide AP incidence is increasing. Most important causes of AP in developing countries such as India include increased alcohol consumption. Contrast enhanced computed tomography plays an important role in diagnosis of the disease and helps in determining the prognosis of the disease. Modified CT severity index scoring system is the most commonly used scoring system for assessment of the severity of the disease. METHODS The present study is a prospective study of patients presenting with signs and symptoms of acute pancreatitis referred to the Department of Radio Diagnosis at Katuri medical college. This study comprised of 50 patients with clinical suspicion / diagnosis of acute pancreatitis, raised pancreatic biochemical parameters like serum amylase and serum lipase. Contrast enhanced computed tomography was performed in these patients, findings reported, and the disease was classified using modified CT scoring index system (MCTSI). RESULTS The mean age of the patients in the present study was 42.3 ± 12.28 years. Most of the patients presented with abdominal epigastric pain, abdominal distension. Acute pancreatitis was divided into acute oedematous pancreatitis and necrotising pancreatitis, the former being common. Complications included, ascites, pleural effusions, splenic vein thrombosis, portal venous thrombosis, and haemorrhages. CONCLUSIONS Contrast enhanced CT is useful to differentiate between oedematous and necrotising types of pancreatitis. The MCTSI helps in better evaluation of pancreatic necrosis grading. The modified computed tomography score index correlation with the development of local and systemic complications in acute pancreatitis is well established. Ideally, conducting contrast enhanced computed tomography (CECT) after 48 - 72 hours of acute attack, increases the probability of identifying necrotising pancreatitis. CT in particular has an overall accuracy of about 87 % and sensitivity and specificity of 100 % in the recognition of pancreatic necrosis. KEYWORDS Computed Tomography, Acute Pancreatitis, Pseudocyst, Modified CT Score Index


2018 ◽  
Vol 8 (3) ◽  
pp. 132 ◽  
Author(s):  
Neha Jindal ◽  
Yamandeep Chauhan ◽  
RamKumar Verma ◽  
PraveenKumar Tyagi ◽  
Madhulata Rana ◽  
...  

Gut ◽  
1977 ◽  
Vol 18 (1) ◽  
pp. 53-56 ◽  
Author(s):  
C W Imrie ◽  
J C Ferguson ◽  
R G Sommerville

2001 ◽  
Vol 33 (1) ◽  
pp. 28-31 ◽  
Author(s):  
Karl Nissler ◽  
Irene Von Katte ◽  
Angela Huebner ◽  
Jobst Henker

Sign in / Sign up

Export Citation Format

Share Document